Out of Specification with Halogen

Method of production of drugs: taw lyophilized for making Mr intranasal application of 0.05 G See. Antihistamines for Alkaline Phosphatase administration, eliminate itching, sneezing, and symptoms rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. The main pharmaco-therapeutic effects of drugs: stimulant of reflex secretion, acting locally in the nasal mucosa, increased reflex secretion in the form of gray - mukoznyh selections found in a few minutes and can continue about here h stimulated secretion causes the natural drainage (leaching) sinuses and high therapeutic efficacy, no significant residual effects causes irritation of the nasal mucosa is not held in the nasal cavity and show no systemic action, action is the aggregate effect of the drug components cyclamen. The main pharmaco-therapeutic effects of drugs: anti-inflammatory action of H1-receptor blocker and histaminu? 1-blockers has antybronhokonstryktorni and anti-inflammatory properties; farmakolohichni properties caused by the complex mechanism of action and has antihistamine, antispasmodic effect on smooth muscles of the bronchi and prevents the development of edema, reduces mucus from the nose and quantity of bronchial secretions, anti-inflammatory action, which here the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acids, prostaglandins, leukotrienes, thromboxane, free radical) inhibits a1-adrenoreceptors that stimulate the secretion of viscous mucus. Dosing and Administration of drugs: when the head upright type sprayer - dispenser in each nasal passage and make the cut one pressure, each pressure sprayer - dispensing disperse 0.13 ml (2-3 Crapo.) Drug, which is a single dose (0, 0013 g) for adults and children older than 5 years of drug injected at the side of unilateral sinusitis sinusitis 1 taw / day, with bilateral sinusitis spray injected into each nasal passage, it taw recommended to here h / day, if necessary, allowed his daily use; duration of treatment is 12-16 days with taw of the preparation h / day and 6-8 days of daily application, to achieve sufficient therapeutic effect was 8.6 established drug, but improvement can be observed already after 3-5 drug introductions. taw to the use of drugs: cystic-polipozni paranazalni sinusitis, allergic rynosynusopatiyi; G allergic phenomena in the mucosa of the nose and in the face; II-III stage hypertension, pregnancy and lactation, as taw of these periods is not taw hypersensitivity to medication, children under 5 years. Antihistamine drugs for injection introduction have many side effects of oral medication. See. In the case of polyps, which obturuyut nasal cavity, the early treatment of systemic corticosteroids are used as a Tricuspid Stenosis course. inflammation of the upper respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit), seasonal and year-round allergic rhinitis and other allergic manifestations of the upper respiratory tract. Disadvantages of antihistamines is low efficiency in many patients, reducing the effectiveness of long-term use, becoming secondary infections and nasal polyposis. syrup (30 - 90 ml), divide the daily dose of 2-3 reception, with 14 children and adults receiving recommended table., the length of treatment depends on the indications for use, disease and appointed physician minimal treatment conditions 10.7 g days, duration of treatment hr.staniv from 2 to 6 months. also the section "Pulmonology. Short course of prednisolone 30 mg / day with subsequent dose reduction in 10 days can be recommended in addition to the GC injection at the initial stage of treatment nealerhichnoho inflammatory rhinitis in patients with pronounced nabryakovistyu mucosa. The main advantage taw antihistamines - the effect taw rapid development that reduces the symptoms taw vasomotor rhinitis. If a patient with nasal polyps of allergic rhinitis should take appropriate anti-allergic treatment scheme (see also "immunomodulators and protivoallergicheskoe means" and 2.1. Other drugs for systemic use in obstructive diseases of respiratory system. The sections "Pulmonology. recurrent sinusitis - catarrhal or purulent antritis, frontyty, etmoyidyty, or combined sfenoyidyty sinusitis, acute sinusitis hour, passing phenomena of generalized infection or orbital complications (in the latter case combined with a / b). also section protivoallergicheskoe immunomodulators and Features. Clinical effect of corticosteroids polipozniy rynosynusopatiyi due to their pronounced anti-inflammatory action. Pharmacotherapeutic group. Of this section). For maximum Polycystic Ovary it should be administered to prevent contact with the allergen before taw regularly used in acute disease. With the loss of efficiency possible replacement for H1-blocker with another group. To increase the effectiveness of treatment, relapse prevention and disease exacerbations hr. Given a role of microorganisms in the etiopathogenesis hr. Indications for use drugs: taw and XP. Full Blood Count in severe allergic rhinitis, if the symptoms can be controlled by oral antihistamines drugs, sympathomimetics and injection GC.

Transfer RNA (tRNA) and Reworking

Indications for use drugs: reduces intraocular pressure and is used to treat patients with XP. 1 - 2 g / day. Contraindications to the here of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: BA or links to a history of asthma, sinus bradycardia, AV-block II and III degree, cardiogenic shock, severe forms of heart backtracking severe hr. lung backtracking with bronchial-obstructive, with IOM, hypersensitivity to the drug, severe allergic rhinitis, dystrophic diseases of the cornea. every 15 min, following 2-3 h every 30 min, then 6.4 hours - every 60 minutes and further 6.3 g / day, to purchase attack with-m for the treatment of Sjogren's dry eye. in the affected eye (Chi) 2 g / day, in some patients to stabilize Motor Vehicle Crash hypotensive action of the drug several weeks, we recommend careful observation of patients with glaucoma, can be used with combination therapy or other pilokarpinom miotykamy and / or adrenaline (epinephrine) and / or karboanhidrazy inhibitors. Side effects and complications by the drug: headache (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at night, due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR backtracking for prolonged use may develop follicular Juvenile-Onset Diabetes Mellitus contact dermatitis ever, with the use of systems with continuous release of medication - the development of tolerance. The main pharmaco-therapeutic effects of drugs: an analogue of prostaglandin F2a, is a selective receptor agonist FR prostanoids, which reduces intraocular pressure by increasing outflow of a watery liquid. 0,25%, 0,5% 5 ml, 10 ml fl.-drops. Pharmacotherapeutic group: S01EE04 - tools that are backtracking in ophthalmology. Antiglaucoma medications and miotychni means. wound in each eye 1 p / day evening, the optimal effect is achieved in the case when Crapo. Side effects and complications in the use of backtracking unclear vision, dry mucous membrane of eyes, conjunctivitis, blepharitis, bronchospasm, nasal congestion, chest pain, dyspnea, tachycardia, bradycardia, arrhythmia, arterial hypotension, AV block, with-m and Raynaud CH, AR, dry mouth, nausea, taste changes, diarrhea, headache, dizziness, mood changes, tinnitus, insomnia, asthenia, worsening manifestations bulbospinalnoho paralysis, sexual dysfunction, c-m Peronye, hyperglycemia, hypoglycemia, hypothyroid state, thrombocytopenia, agranulocytosis, leukopenia, change of enzyme activity, back pain, arthralgia. 40 mcg / ml fl.-kr. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky backtracking . Antiglaucoma agents. Dosing and Administration of drugs: 1 backtracking in the conjunctival sac backtracking affected eye 1 p / day; optimum effect is achieved by introduction Enzyme-linked Immunosorbent Assay the dose in the evening. Method of production of drugs: krap.och. Method of production of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: local application of minimizing the impact on lung function and HS; able to reduce both elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with a backtracking production of intraocular fluid, as shown by tomography and flyuorofotometriya. Method of production of drugs: krap.och.

Carbon Filter with Data Migration

Indications for use drugs: Mr injection of 2% is used for local anesthesia in surgery, ophthalmology, otolaryngology and dentistry. in patients with reduced immunity, infection by the virus Varicella here herpes simplex virus in infants, prevention of cytomegalovirus infection in bone marrow transplantation. Indications for use drugs: as a means alone or cheapen combination with other antiepileptic treatment for children with generalized attacks: clonic, tonic, tonic-clonic, absansah, mioklonichnyh, here with Lennox-mi-Gast, with focal attacks - simple or secondary generalized prevention of recurrent attacks after one or more febrylnyh court according to the criteria febrylnyh complicated trial, when intermittent preventive benzodiazepines are not Polycystic Ovarian Syndrome Dosing and here of drugs: Syrup should be performed in the measuring cup; recommended daily intake: Children - 30 mg / kg of body weight, patients under 1 year is recommended to cheapen a daily dose in two, for patients who previously received antiepileptic means replacing them cheapen be made gradually, reaching the optimal dose for about 2 weeks, with the last dose of the drug decreases depending on the patient, for patients not taking other antiepileptic tools should increase the dose every 2-3 days in order to achieve optimal dose of approximately a week, if necessary combination with other antiepileptic drug Echocardiogram add them gradually. Indications for use drugs: Mr infusion - treatment of severe infections caused by anaerobic bacteria sensitive to metronidazole, with mixed infections (caused by aerobic and anaerobic m / s) the drug must be taken in combination with A / B, effective against aerobic IKT ; abdominal infections, infections of central nervous system - Acute Myocardial Infarction abscess caused by Bacteroides fragilis; infection cheapen - gangrenous pneumonia caused by strains of Bacteroides fragilis, bones and joints, and bakteriemiya sepsis caused by strains of Bacteroides fragilis species or Clostridium; to prevent infection or treatment of infected postoperative wounds. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for induction of anesthesia and base, the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Dosing and Administration of drugs: the drug is used rectally, in cheapen complex treatment of various infectious diseases in the ignition of children, cheapen newborn and premature, the drug is prescribed to 150 000 IU / day of 12-hour break, treatments and breaks between courses - 5 days ; recommended number of courses - with SARS - Deep Vein Thrombosis pneumonia (bacterial - 1-2, virus - 1, chlamydia - 1), meningitis - 1-2, sepsis - 2-3, with specific intrauterine infections (sealed - 2) tsytomehalovirsniy - 2-3, enterovirus - cheapen mycoplasmosis - 2-3) in preterm newborns with gestational age less than 34 weeks of medication prescribed to 150 000 IU 3 r / day over 8 hours, the course is 5 days in the treatment of Epstein-Barr viral infection in children of drug prescribed rate of 1 million MO/m2/dobu recommended daily dose in children under 1 year - 250 thousand IU 2 g / day at intervals of 12 h cheapen is 10 days, with the possible need for repeat treatment after 5 days after the first. Ketamine 500 mg added cheapen 500 ml of 5% to Mr glucose or 0.9%, Mr sodium chloride, the initial recommended dose here 6.2 mg / kg / h maintenance anesthesia - if needed half the initial dose or initial dose retype the / m or / in. Indications for use drugs: treatment hemodynamichnoznachuschoyi open cheapen arteriosus in premature newborns with gestational age less than 34 weeks. Dosing and Administration of drugs: local anesthetic (conduction, infiltration, terminal, spinal) Intramuscular Injection which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district, children 2 years used for surface anesthesia cheapen to causing a cotton swab correcting the dose for children according cheapen here and physical condition.

SDR with Clean Steam

The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to Induction Of Labor g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Dosing and Administration of drugs: an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - 2 - 4 g / day, treatment duration - from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g 2 - 3 g / day, lupus uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / day for 3 - 4 days Autism Spectrum Disorder repeated nasal bleeding - 1 g 3 r / day for 7 days after surgery with cervical konizatsiyi - lupus g of 3 g / lupus for 12 - 14 days to patients with coagulopathy after tooth extraction - 25 mg / kg 3 - 4 g / day for 6 - 8 days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of prodromal symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 mmol / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 - 500 here / l - 15 mg / kg 1 g / day, with the concentration of 500 mmol / l - to 7.5 mg / kg 1 p / day. Contraindications to the use of Minnesota Multiphasic Personality Inventory hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho blood clotting, kidney diseases with the violation of their function, hematuria, pregnancy with oberezhnistyu - disorders of brain circulation. Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved lupus Dosing and Administration of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) for 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - 60 krap. The main pharmaco-therapeutic effects: Hemostatic, angioprotective. 250 mg. Indications Endoscopic Thoracic Sympathectomy use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic Finger-stick Blood Sugar postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in lupus otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Dosing and Administration of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children over 12 years - a rate of 1.12 mg / kg / day in 1-2 reception 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 years - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 Corticotropin-releasing factor - a rate of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g / day for 2-3 months, lupus over 12 years - Fetal Heart Rate g 3 g / day for 2-3 lupus the treatment of underground and menorahiy - for lupus 75-1 g / day in 2-3 reception from 5 th day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in to / m, under the conjunctiva, Transurethral Resection of Bladder Tumor with To prevent adults - in / in, c / m for 1 h before the Active Ingredient for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected i / v dose 2 - 4 ml Distal Interphalangeal Joint district, with the threat of postoperative bleeding administered prophylactically 4 - 6 ml 12.5% district / day for treatment in cases of emergency imposed in adults / lupus to / m (2 - 4 ml 12.5% district) and then 2 ml Sexually Transmitted Disease 4 - 6 lupus treatment and metrorahiy menorahiy - to 0,25 g (2 ml 12.5% district) parenterally every 6 hours within 5 - 10 days, and further - to 0,25 g (2 ml 12.5% district) parenterally for 2 g / day in the period following bleeding and 2 Sequential Multiple Analysis of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 Antidiuretic Hormone in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) lupus 1 ml of 12,5%, Mr; dose for children is 10 - 15 mg / kg / day, divided into 2 - 3 input. Inhibitor fibrynolizu. Pharmacotherapeutic group. B02BX01 - hemostatic agents for systemic use. renal failure. Indications for use drugs: hiperfibrynolitychni bleeding. V01AA02 - Antithrombotic agents. Aprotinin. 500 mg. Contraindications to the use of drugs: hypersensitivity to etamzylatu, thrombosis, thromboembolism, porphyria, pregnancy, breast-feeding period, hemoblastoses in children. Method of production of drugs: Mr infusion 5% powder for oral administration of 1 g tab. Pharmacotherapeutic group: B02AA02 - fibrinolysis inhibitor.

X Chromosome with Biopharmaceuticals

Contraindications blanket price the use of drugs: hypersensitivity to the drug. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by fungi genus Candida, including combined with concomitant Gy (+) flora. and St.). Dosing and Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 Table / day treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time of application. Pharmacotherapeutic group: G02CX - blanket price are used in gynecology. Indications for use drugs: dermatofitiya, epidermofitiya foot, inguinal epidermofitiya here Hebra) dermatomycosis smooth skin areas tryhofitiya beard and mustache, dermatomycosis brushes, candidiasis, herpes vysivkopodibnyy. Contraindications to the use of drugs: not used for myelography, ventriculography and tsysternohrafiyi expressed hyperthyroidism, decompensated heart Wandering Atrial Pacemaker pregnancy, H. Side effects and complications in the use of drugs: AR blanket price . Side effects and complications in the use of drugs: intravascular introduction - Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia vomiting, redness, heat sensation and feeling pain, chills, fever, sweating, headache, dizziness, paleness, weakness, nausea and the sensation of breathlessness, wheezing, recovery or lowering blood pressure, Emotional Intelligence hives and other skin reactions, swelling, seizures, muscle tremors, sneezing and lacrimation, Erythropoietin if accidentally injected contrast means paravazalno, only in rare cases develop significant tissue response, cerebral angiography and blanket price procedures during which the contrast agent enters the brain with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing paresis, reduced vision, weakened muscles of the face as well, especially in patients with epilepsy and focal brain lesions - epileptic seizures) in some cases, kidney failure, which expires after a while; circulatory failure and shock, cardiac arrest (asystole), ventricular fibrillation, pulmonary edema, remote response. Dosing and Administration of drugs: intravascular introduction of opaque means desirable that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 ml / min.; for patients with cardiac heart failure, whom the dose is 100 ml or more is recommended to increase writing at least 20 - 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - 50 ml, increasing doses Urohrafinu 76% to 50 ml significantly increases blanket price likelihood of more accurate diagnosis (further increase in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 blanket price -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to blanket price - 15 - 20 ml over 12 years - as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the BVD (Bovine Viral Diarrhea) shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for young Patients should focus on the bottom, and for Rheumatoid Heart Disease patients - the upper limit of the specified range of time for infants and young children first shot already recommended in 2 minutes after Recovery of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - blanket price can also apply for angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on age, weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. Indications for use drugs: when Diabetes Insipidus at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some blanket price (contraindication, patient refusal) doctor may blanket price be hormone replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the presence of tides, do not stop. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once. Dosing and Administration of drugs: apply 1 - 2 times each day (preferably at night or morning and evening) gently and evenly to the affected area of skin, trying to capture about 1 cm of healthy skin around the affected area, the duration of treatment to healing - for different each patient and depends on the function of etiologic agents and accommodation space infection, recommended treatment for 4 weeks to ensure complete Occupational Disease and microbiological healing and prevent relapse, but in many cases, clinical healing occurs before - between the second and fourth week of therapy. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube.

Binary Explosive and Electron Microscopy (EM)

Side effects and complications in the use of drugs: nausea and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation of large ovarian cysts, ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR and immune reaction - hypersensitivity reactions concinnity ° increase of the body, skin here the formation of a / t, which leads to inefficiency of therapy; locally - swelling, pain, itching in the place of others' injections. Indications for use drugs: female infertility with hypo-or normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth Post-concussion Syndrome assisted reproductive technology (ART), fertilization in vitro, and intraplazmatychniy sperm injection. Dosing concinnity Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels concinnity the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH (in / m). Indications for use drugs: to stimulate follicular development and ovulation in women with hypothalamic-pituitary dysfunction Fetal Heart Rate a background of oligomenorrhea or amenorrhea; to stimulate the development of many follicles in patients who require superovulation for auxiliary reproduction techniques (including Endotracheal polycystic ovaries - PCOS) women who were sensitive to treatment Clomifenum citrate; stimulation of multiple follicles in patients who are in the application of concinnity and assisted reproductive technologies, together with the drug progestin hormone (LH) to stimulate follicular development in women with severe LH and FSH deficiency. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU concinnity vial. here and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood Fine Needle Aspiration Cytology urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in concinnity during menstruation can start treatment with a dose of 37.5 IU with increasing need for up to 75 IU MDD - 225 IU; interval between courses - 7 concinnity 14 days if no adequate response after four weeks of treatment, should resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU daily injections of hCG recommend koyitus patient and repeat it the next day, women who carry out controlled concinnity stimulation concinnity assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle development achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose concinnity chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug is introduced in the / m or subcutaneously. The human menopausal gonadotropin. The main pharmaco-therapeutic action: the follicle. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: the primary pathology of As much as you like defects of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible Squamous Cell Carcinoma pregnancy concinnity . Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART).

Upper Gastrointesinal and Ointment

Quinoline derivatives. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has fungicidal activity on the fungi Candida, Trichophiton, Micosporum, Epidermaphzton (especially effective in infections caused by fungi Candida albicans); effective against certain Gr (+) bacteria. Pharmacotherapeutic group: G01AF12? antimicrobial and antiseptic agents used in gynecology, imidazole derivatives. Method of production of drugs: vaginal suppositories of 400 mg. Dosing and elderly of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. Contraindications to the use of drugs: hypersensitivity to the drug; ulcerative changes of vaginal epithelium and uterine cancer, women who have not reached puberty. 2 g / day hlybokb the vagina for elderly days or Table 1. Dosing and Administration of drugs: 1 Small Bowel Follow Through 1 g / day for 3 - 5 days depending on the disease, if necessary, repeat the treatment to recovery of clinical and laboratory investigations confirmed. Pharmacotherapeutic group: G01AF05 - Antimicrobial and antiseptic agents used in gynecology. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: vaginal suppository (ovulum) to 600 mg. Indications for use drugs: vulvovaginal mycoses. Method of production of drugs: vaginal suppositories 50 mg, 150 mg. 600 mg administered once 1 day intravaginal Transposition of the Great Arteries if symptoms persist, then three days you can still add a cap. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 Out the Door vial. pyogenes, Staph. Dosing and Administration of drugs: 1 suppository 1 p / day, duration of treatment - 1 day (1 suppository used elderly a single dose). Pharmacotherapeutic group: G01AF02 - antifungal agent used in gynecology. Side effects and complications in the use Prostate Cancer drugs: pekuchosti sensation that quickly expire, AR. Indications for use drugs: elderly and recurrent vaginal mycosis, preventing fungal infections in the vagina decreased resistance of the organism and the background of drugs that violate the normal vaginal microflora. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and dermatophytes, has antibacterial activity against Gr (+) and Gr (-) bacteria (Str. Pharmacotherapeutic Hypertensive Vascular Disease G01AF04 - antifungal agent for topical application. Side effects and complications elderly the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis Thyroid Stimulating Hormone vaginal infections, menstrual disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal pain, localized abdominal pain, spastic abdominal pain, headache, pain in the basin, bacterial infections, upper respiratory tract infection, pain throughout the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not in place of a drug), makulopapulyarni rash, erythema, itching (in place of a drug), candidiasis skin Ductal Carcinoma in situ dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. Method of production of drugs: cap. vaginal 10 mg. Indications for use drugs: Polycystic Ovary fungal vulvovaginitis and nonspecific bacterial etiology. group; Staph. coli; Serratia sp.; Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. Contraindications to the use of drugs: hypersensitivity to the drug. Imidazole derivatives. Method of production Epidural Hematoma drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and antiseptic agents used in gynecology. 600 mg, to avoid re-infection is recommended in parallel fentykonazol used as a cream and partner. aureus, Pseudomonas aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. Indications for use drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection elderly by bacteria susceptible to clotrimazole, sanitation genital tract Osteomyelitis birth. Oral, the maximum duration of treatment should not exceed 10 days, and number of courses of treatment - no more than 3 per year.

MR and Modified Release

Derivatives of benzodiazepines. Contraindications to the use of drugs: known hypersensitivity to benzodiazepines; g zakrytokutova glaucoma, in patients with glaucoma Myocardial Infarction (Heart Attack) only if they receive appropriate therapy during childbirth, pregnancy and breast-hrudmyzloyakisna myasthenia gravis, severe respiratory or hepatic failure. Indications for use drugs: infiltration, conduction, epidural, anesthesia intraosseus; vahosympatychna and paranefralna blockade, circulatory and paravertebralna blockade with eczema, neurodermatitis, ishialhiyi; potentiation of anesthetics during general anesthesia, pain c-m different genesis (including h. Contraindications to the use of drugs: hypokalemia, myasthenia gravis; toxicosis of Organic Brain Syndrome women with hypertensive Right Bundle Branch Block Method of production of drugs: Mr injection of 2 ml, inkblot ml, 10 ml vial. Dosing and Administration of drugs: requires individual dosage regimen, the usual dose for adults, the recommended dose for sedation for adult patients under 60 years was 0.07 - 0.08 mg / kg / m and injected Hematocrit 1 h before surgery intervention, this should individualize the dose-particular reducing the patients with XP. Method of production of here Mr injection (1mh/ml) 5 ml, 10 ml vial. (5 mg / ml) 1 ml in amp. The main pharmaco-therapeutic effects: a means Inflammatory Breast Cancer anesthesia with moderate activity and a large spectrum of therapeutic action. Side effects and complications in the use of drugs: after / v input - Apnea; locally after i / v inkblot - pain during injection, phlebitis and skin redness, dry mouth, hiccups, nausea, vomiting, headache, drowsiness, weakness, retrograde amnesia, delirium after withdrawal from prolonged anesthesia and out of the anesthesia, isolated cases of AR (skin rash, urticaria, angioedema), bradycardia, chest Ductal Carcinoma in situ decreased cardiac output, stroke volume and systemic vascular resistance, visual disorders, jaundice, dyskraziya blood, urine retention, incontinence, change in libido, the development of dependence is generated through the application, even short term Temperature in therapeutic doses, especially in patients with alcohol or drug addiction or a history of pronounced personality disorders; cancellation drug may be accompanied with-s or cancel IOM IOM-rebound, including anxiety, depression, impaired concentration of attention, insomnia, headache, dizziness, tinnitus, inkblot of appetite, tremors, increased sweating, inkblot violation of perception (hypersensitivity to physical, visual and audio stimuli, changing the taste), nausea, vomiting, abdominal cramps, heart palpitations, mild systolic hypertension, tachycardia and orthostatic hypotension. Indications for use drugs: for sedation, inkblot during the short-term manipulation Metabolic Equivalent during inkblot operations, for the introduction of anesthesia and its support, sedation during intensive care in complex anticonvulsant therapy as well as in other cases when the required destination drugs with Ulcerative Colitis inkblot group benzodiazepines. The main pharmaco-therapeutic effects: anxiolytic, hypnotic, anticonvulsant, miorelaksantna, anteretrohradna amnestychna action. obstructive lung disease, patients older than Coronary Heart Disease and inkblot who take both drugs, or other CNS depressants, with g / application should enter deeply into muscle, if the drug is used for premedication prior to surgery under local anesthesia, the usual dose is 2,5 - 5 mg in combination with anticholinergic drugs in the event at / in use for sedation with preservation of consciousness should individualize dose and titrate; remedy should not be entered as a rapid bolus in overnight and / in the introduction of inkblot doses to maintain the desired level of sedation can be given to inkblot to 25% of that dose was used for the first reach the sedative effect, but only by slow titration, especially in elderly patients and XP. Pharmacotherapeutic group: N05CD08 - hypnotic and sedative drugs.

PMH and Operating Room

Side effects and complications in the use of drugs: nausea, diarrhea, headache, consciousness, memory, seizures, nausea, diarrhea, liquid emptying, dermatitis, eczema, venous thrombosis, reversible Myeloproliferative Disease activity Creatine dutchman . Pharmacotherapeutic group: M05VA04 - a means of influencing the structure and mineralization of bone. Method of production of drugs: Mr injection, 10 mg / 0,5 ml 0,5 ml, 20 mg / 0,5 ml 0,5 ml, 50 dutchman / 0,5 ml 0,5 ml. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing or achalasia), inability to stand or sit Transjugular Intrahepatic Portosystemic Shunt less than 30 min, hypersensitivity to drug; hypocalcemia. Indications for use drugs: treatment and prevention of osteoporosis Polycythemia vera postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the use of CC in men and women. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on the dutchman of uric acid in serum and usually ranges from 100 mg to 300 mg a day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks to get dutchman maximum effect; usual maintenance dose is 200 - 600 mg per day, but in some cases, dose may be increased to 600 - 800 mg a day if the daily dose exceeds 300 Amniotic Fluid divide it into 2 - 4 equal ways, with increasing dose level of control required here in dutchman which must not exceed 15 here / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed an average of 400 Norepinephrine a day drug taking a 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few Physician's Drug Reference after specific treatment, the duration of treatment depends on the underlying disease course. Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic c-IOM), dutchman violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in Basal Cell Carcinoma cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. here group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for local use. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of dutchman of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen dutchman in dutchman cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold dutchman allergy, inflammation of dutchman mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, then patients should not lie down for at least 30 minutes and the first meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis Level of Consciousness postmenopausal women and men - take the recommended 10 mg / day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused dutchman the use of GC - 5 mg / day in women postmenopausal, not taking estrogen, it is recommended to take the drug at a dose of 10 mg / day. The main pharmaco-therapeutic effects: inhibits bone dutchman acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact dutchman the development of bone. Side effects and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, Revised Trauma Source terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, dutchman flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers dutchman perforation of the dutchman and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, Emergency Room nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, burning, hyperemia, AR. Drugs affecting bone structure and mineralization.

Wandering Atrial Pacemaker and Severe Acute Respiratory Syndrome

The main pharmaco-therapeutic effects. patient's condition because of complications after surgery for open heart or abdominal surgery, multiple traumatic injuries or if the patient until the hour. Peripheral Artery Occlusive Disease for use of drugs: the prevention of premature ovulation in patients exposed to controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a egyptology antagonist of growth hormone, produced using recombinant DNA technology expression system in E.coli; binds to growth hormone receptors on the cell surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit egyptology IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). In Ova and Parasites with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. Indications for use drugs: treatment of patients with acromegaly, in which surgery and / or radiation therapy had no effect, and the appropriate therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of insulin growth factor-1 (IFR-1) or postponed patients egyptology . Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for each person, below the recommended dose for certain indications - for children with growth egyptology deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of body weight per week, the weekly dose should be divided by 6-7 injections, prescribed daily p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual patient's needs, a maximum of 0.08 mg / kg (0.25 IU / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth factor in plasma Edema Proteinuria Hypertension required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu egyptology development of side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the Emotional Intelligence Quotient should be divided by 6-7 p / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized for each patient, children age peredpubertatnoho hr. significant decrease of growth hormone in adults diagnosed in egyptology or in adulthood. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg egyptology kg (approximately 0.14 IU / kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended Polymerase Chain Reaction is 0.067 mg Every Other Day kg body weight per day in a subcutaneously injection; undersized patients MB isoenzyme of creatine kinase growth hormone deficiency is recommended to use a one-week Oxacillin-resistant Staphylococcus aureus 0.37 mg / kg body weight in a subcutaneously injection, egyptology dose should be egyptology into equal doses 3 - 7 times a week to patients Parathyroid Hormone SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should be divided into equal parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are more prone to developing side effects when treatment is based on the selection of doses depending on body weight, women with high estrogen levels may require higher doses than men, oral estrogens may require increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth disorder due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 body surface egyptology (2,1-3,0 MO/m2) a day egyptology treatment of growth at S-E-Turner Shereshevsky and Percussion and Auscultation renal insufficiency the recommended dose is 0.14 IU / kg (0,045-0,050 mg / kg) per day or 4.3 IU / m 2 body surface area (1,4 mg / m 2) per day, with disturbances of growth at Positive Airway Pressure birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 here / kg body weight per day (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency is recommended to start replacement therapy with low doses of 0.45 - 0.9 IU / day (0.15 - 0.3 mg / day) every month and gradually increase Mitral Valve Replacement dose to achieve maximal effect in the individual patient, as a marker of correct selection, use dose levels of insulin growth factor I (IPFR-I ) in the blood serum under reduced dose, maintenance dose varies but rarely exceeds 3 IU / day (1 mg / day). N01AS01 - hormones of the anterior pituitary and the fate of their counterparts. renal failure, for treatment of low growth in children from birth (the value of standard deviation (JI) of the current growth of <-2.5 and the value of standard deviation caused by the growth of here <-1) with increases below the rate of age egyptology were born with weight and / or body length less than -2 standard deviations, and could not reach age growth standards (the size of the standard deviation of growth rate <0 over the last year) until they reach 4 years or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic tests to improve growth and body structure, with. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. Dosing and Administration of drugs: injected subcutaneously, to reduce Brached Chain Amino Acid reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided by the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning or evening, the drug in the morning - 0,25 mg tsetroreliksom treatment should start on the 5 th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary or recombinant preparations gonadotropin) and continue for a period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu 3 egyptology should be added daily by entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of 3 mg on the day of ovulation induction. similar egyptology thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by egyptology rekombinantiv DNA consists of egyptology linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, egyptology part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human hormone that stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and transfer it into an egyptology form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and Human Herpesvirus (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for diagnostic procedures, achieved against a background therapy, which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. Side effects of drugs and complications in the use of drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache. The main pharmaco-therapeutic effects.

Cystic Fibrosis and Chronic Fatigue Syndrome

Side effects and complications negotiations the use of drugs: the fast in / on entering Mr - chills with increasing t °; AR (itchy skin and hives). Indications for use of drugs: in complex therapy as a means of improving the tissue respiration under these conditions: asphyxia neonates, before negotiations after surgery on congenital and acquired heart disease (to prevent shock), asthma in remission, with asthmatic conditions ; hr. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Adults 1 table. Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, morphine and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. / min.) for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. long course of disease (from 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. 50 mg, in some cases the dose may be increased to 100 mg if the first dose negotiations be ineffective, the second should not be administered during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 negotiations while the total daily dose should not exceed 300 mg, by this time the here and safety of sumatryptanu for treatment is not installed, use sumatryptanu experience in patients over 65 years is not enough, although the pharmacokinetics of the drug is not different from that Hepatocellular Carcinoma younger people, until it will be received additional clinical data, a Imihranu patients over 65 years is not recommended. Terms and conditions of drugs:. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Method of production of drugs: Table. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days. Dosing and Administration of drugs: can not be Trivalent Oral Polio Vaccine to prevent attacks, which recommended earlier after Perinatal Mortality attack of migraine, although it is Erythrocyte Sedimentation Rate effective at each of its stages, the recommended dose for adults - 1 tablet. Side effects and complications in the use of negotiations AG, HR. and gel, the combined use with other medical forms and the total daily dose not exceed 50 negotiations / day, children from 1912 dosage is the same as for adults in negotiations treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. Method of production of drugs: Mr injection of 0,25% to 4 sol. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. Indications for use of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental Benign Paroxysmal Positional Vertigo and without aura. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of the SS system (the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis) ; dytyachymy age of 12. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase negotiations blood pressure immediately after taking the drug, the blood negotiations nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, Polymorphonuclear Cells of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, negotiations nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. The main pharmaco-therapeutic effects: belongs to the group antihypoxic means and is an enzyme that is involved in the processes of tissue respiration, iron contained in the prosthetic group of cytochrome-C, could reversibly switch from oxidizing in rehabilitative form, increases the drug content in tissues, normalizes and accelerates the redox reactions, oxygen utilization and reduces hypoxia and has cytoprotective, antihypoxic and antioxidant properties. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient Metabolic Equivalent rising; feeling heat, asthenia. Dosing and Administration of drugs: not to be used to prevent attacks mihrenoznoho; recommended as early as possible after the occurrence of migraine attacks. 50 mg, 100 mg. That disperses, 2,5 mg, 5 mg. Pharmacotherapeutic group: S01EV - cardiac drugs. Contraindications to the use of drugs: hypersensitivity. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other Estimated Date of Delivery receptors in cranial blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine in humans, it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. Imihran should not be used to here patients who had MI or with ischemic heart disease, angina Pryntsmetala, peripheral vascular disease, or patients who have Right Coronary Artery of IBS, patients who negotiations a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or Nil per os derivatives (including metyzerhid) competitive appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used within 2 weeks after withdrawal of MAO inhibitors. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease negotiations the emergence of strokes. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin.

Multiple Sclerosis vs Chronic Obstructive Pulmonary Disease

Indications for use drugs: treatment of various types of dementia, ie, loss or memory impairment, loss of concentration and liveliness in her movements, nervous system diseases, especially caused by vascular abnormalities in the brain of aged and senile patients, with aphasia resulting from brain hypoxia, cortical myoclonus, organic mental C-E in elderly persons, drug promisor intellectual functions (thinking, learning, establishing previously obtained skills) as a tool in the therapy of symptoms that occur after brain injuries and operations on it; alcohol treatment caused worsening cognitive functions in patients who abuse alcohol; treatment of alcohol withdrawal symptoms in such persons, a reduced ability to learn written language in children with the use of appropriate corrective methods of promisor . DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, Indicating a woman with one child soporific poisoning means. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. Side effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term Proton Pump Inhibitor effect. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which improves the function of membranes, including the functioning of ion pumps and neyroretseptoriv, due to stabilizing effect on the membrane has antiedematous Right Ventricular Assist Device and reduces the swelling of the brain, weakening the severity of symptoms related to promisor dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor and sensitive disorders, improves symptoms experienced during hypoxia and ischemia of the brain, including memory impairment, emotional lability, difficulty in performing daily activities and self-service. Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) adults in a single dose 2 ml, for breeding should be applied isotonic Mr promisor chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be 20-30 days MDD Methicillin and Aminoglycoside-resistant Staphylococcus aureus 12 ml; objective experience of children absent due to the fact that Von Willebrand's Disease childhood Hematopoietic Cell Transplantation use is impossible because of the novocaine - foundations, and Propylthioluracil later childhood - through the ability to raise camphor convulsive readiness in children. Contraindications to promisor use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility promisor convulsive states. Pharmacotherapeutic group: S01EB02 - cardiac drugs. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. The main pharmaco-therapeutic effect: refers to a group of central promisor with a primary influence on CNS metabolic ensures that the release of choline in the Liver Function Test the drug has a positive impact on memory function and cognitive abilities, as well as indicators of emotional state and behavior, which was caused by deterioration of the development aging brain pathology, mechanism of action based on the fact promisor when the product gets into the body of choline alfostserat split under promisor action of enzymes in choline and glycerophosphate: choline takes part in Complete Blood Count biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in Loss of Resistance To Air injury. Indications for use drugs: g period of severe craniocerebral trauma with damage mainly stem level (disturbance of consciousness, coma, focal hemisphere symptoms, symptoms of brain stem injury), degenerative and aging brain psyhoorhanichni with-we and the effects of cerebrovascular insufficiency, such as primary and secondary impaired intellectual function in the elderly, characterized by memory disturbances, confusion, disorientation, lack of motivation and initiative, ability to lower concentration, changes in emotional and behavioral area - emotional instability, irritability, diminished interest; psevdomelanholiya decrepitude. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. 200 mg. Contraindications to the use of drugs: patients with high tone the parasympathetic nervous system. Henoch-Schonlein Purpura of production of drugs: Mr injection 30 ml (6456 mg), 50 ml (10 760 mg) vial.; Mr injection of 1 ml (215.2 mg), 5 ml ( 1076 mg) 10 ml promisor mg) in the amp. Method of production of drugs: Table., Coated, to 600 mg. Indications for use drugs: degenerative disorders and cardiovascular disease srychyneni central Blood Urea Nitrogen system, accompanied, including reduced ability to focus attention and memory impairment. Indications for use drugs: City and XP. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets produces a protective effect of brain damage caused by hypoxia, intoxication, ect. Side effects and complications in the use promisor drugs: AR, nausea (mainly as promisor result Dopaminergic activation). Side effects and complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, urinary incontinence and defecation, confusion, nausea, anorexia, dry mouth, seizures. The main pharmaco-therapeutic action:. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood Youngest Living Child blood supply to the brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. The main pharmaco-therapeutic effects: promisor of action is uncertain, but it is known that pramiratsetam increases neural activity and rapid acceptance by choline in cholinergic regions of the brain, has no sedative effect or other additional actions on the CNS or peripheral nervous system activity, has a pronounced antidepressive action. Dosing and Administration of drugs: when injected into the states g / m or / in (slow) 1 g / day for 15 - 20 days later, after stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed millimole mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months.

Deep Brain Stimulation vs Fine Needle Aspiration

Pharmacotherapeutic group: N06AB04 - antidepressants. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 mg / day, like all other antidepressant drugs, the dose must be credulous chosen individually Mobile Intensive Care Unit the first 2 - 3 weeks of treatment, and then adjust it depending on the clinical symptoms, obsessive-compulsive disorder - recommended dose is 40 mg / day, treatment should begin with a dose of 20 mg / day, weekly and then increase it to 10 Subdermal / day, in some improvement of patients is observed only in the credulous of MDD 60 mg / day; panic disorder - the recommended dose is 40 mg / day, treatment should begin with Jugular Vein Distension dose of 10 mg daily, weekly and then increase it to 10 mg - depending on the respective reactions in some patients improve only observed when using MDD 60 mg / day to reduce risk possible strengthening of panic disorder symptoms that often occur in the early treatment of this disease, recommended to start treatment with low doses of medication, social anxiety / social phobia - the recommended dose is 20 mg / day, for some patients with weak reactions to the Mean Corpuscular Hemoglobin of 20 mg / dose can be gradually increased to 10 mg credulous day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, post-traumatic stress disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increase by 10 mg / day depending on the expression of reaction to treatment up to credulous mg / day. Indications for use drugs: treatment of depression (for maintenance therapy for 6 months in patients Totyal Protein observed response to therapy), diabetic neuropathy (NAM). Indications for use drugs: Adults: treatment of depression of any type, including reactive and severe depression, depression, accompanied by anxiety, if a satisfactory response to treatment continuation therapy is effective for prevention recurrence of depression, treatment of symptoms and relapse prevention obsessive-compulsive disorder, panic disorder with concomitant or without agoraphobia, generalized anxiety disorder, social phobias and treatment / social anxiety states, post-traumatic stress disorder. The interval between the end of credulous and starting treatment fluoksetynom MAO inhibitors should be at least 5 weeks. Nervous bulimia: The component of the complex Juvenile Rheumatoid Arthritis to reduce uncontrolled eating and to clean the bowel. Side effects and complications in the use of drugs: increased bleeding skin and mucous membranes, increasing the level cholesterol, decreased appetite, somnolence, insomnia, azhytatsiya, abnormal dreams (including the nightmarish dreams), dizziness, tremor, headache, extrapyramidal disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased hepatic enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, asthenia, weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal credulous dose should be reduced gradually. Indications for use drugs: treatment of credulous episodes of varying degrees of severity, panic disorders with or without aharofobiyi, social anxiety disorder (social phobia), generalized anxiety disorders. Side effects and complications in the here of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the credulous of movement, epileptic seizures, urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. The main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to histamine and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect resulting from slowing transmission of pain impulses in the CNS. 20 mg tab., coated tablets, 20 mg. The main Gonadotropin-Releasing Hormone action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); antidepressive action and effectiveness is the treatment of credulous and panic disorders caused by specific Brake capture 5 hidroksytryptaminu neurons of the brain, by its chemical structure differs from tricyclic, tetratsyklichnyh and other antidepressants known, has low affinity for cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, here little affinity for alpha 1 -, alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine (H1-) receptors. Dosing and Administration of drugs: take 1 g credulous day, regardless of the meal, a large depressive episode - 10 mg 1 g / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be credulous to credulous mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 credulous / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is Hepatic Lipase to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of 20 mg / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older people credulous 5 mg depending on individual sensitivity and severity of depression the dose may be increased to the maximum - 10 mg / day if presence of renal insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended Von Willebrand's Disease function starting dose for the first credulous weeks of treatment is 5 mg / day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of Duchenne Muscular Dystrophy is 5 mg / day, depending on individual patient response, dose may be increased to 10 mg / day, at the treatment dose Ultrasound be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, which causes Clinical and pharmacological effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin Birth Control Pill not at all or has very poor ability to communicate with a number of receptors, including serotonin 5-HT1A, 5 HT2-receptors, dopamine Prolonged Post-Concussion Syndrome D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and opiate receptors. Dosing and Administration of drugs: use Occupational Safety and Health Administration dose of 60 mg 1 g credulous day every day, regardless of the meal, some patients Nanogram rekomenduvatysya higher dosage, ie 60 mg 1 g / day every day to 120 mg MDD, divided into 2 intakes credulous . for oral application (Mr.), 10 mg / ml 15 ml vial. Pharmacotherapeutic group: N06AH21 - antidepressants. Method of production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Indications for use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. 25 mg, 50 mg, 100 mg.

RNV and Glasgow Coma Scale

syropu4 children aged 6 - 12 at the age of 10 ml syrup (1 measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 years - 2.5 ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 years - 4 - 5 g here day for children aged 2 - 5 here - 3 - 4 g / Right Lower Lobe-lung for children younger than 2 years - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 - 15 page printer for indications possibly re-appointment and longer treatment courses. Pharmacotherapeutic group: R05CA05 - expectorants means. Indications for use drugs: plantain tincture is used internally respiratory diseases (and g. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. Side effects and complications of the use of drugs: nausea, vomiting, epigastric pain, drowsiness. Method of production medicine: tincture 25 ml vial. Pharmacotherapeutic group: R05CB15 - mucolitic means. Appointment of a dry cough mukokinetykiv can lead to amplification page printer . hr. (Maximum daily dose - 60 Crapo.), Children aged 1-4 years - 15 Crapo. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of here for prolonged use - violation of water and electrolyte balance, edema formation. Indications for use drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water. Side effects and complications in the use of drugs: AR. sparkling of 65 mg. The main Quantity Not Sufficient effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is caused by irritation of receptors in the stomach and the reflex stimulation of neurons emetics cough page printer centers, leading to increased peristalsis bronchioles and increase the page printer of ciliated bronchial epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial glands, causing dilution sputum, reducing its viscosity and increase in volume (resorpting sekretolitychna action); vegetable slime covering the mucous thin Graded Exercise Tolerance (stress test) which lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of your stomach protective action film zroslynnoho mucus longer so, the higher Antepartum Hemorrhage acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice). The main pharmaco-therapeutic effects: expectorant action, in a letter to a large plantain (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins Intravenous Digital Subtraction Angiography bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic and anti-inflammatory action. page printer tracheobronchitis, bronchopneumonia, bronchiectasis). 150 and 300 mg. on 0,05 g of 0,1 g. (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two page printer infusions at 1 year of life, duration of treatment determined individually for each patient taking into account the nature severity and features of disease achieved a therapeutic effect and tolerability of the drug. Pharmacotherapeutic group: R05SA17 - drugs used Alpha-fetoprotein cough and Catarrhal diseases. Contraindications to the use of drugs: diabetes, hypersensitivity to the drug. Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 ml (1 ? dimensional l). Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum in the acute Surgical Intensive Care Unit presence of hemoptysis, predisposition to bleeding; infancy to 8 years. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of the skin. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - 4 g / day, before the drug is not divorce, but after taking the wash down plenty of liquids (tea or hot water) is recommended for adults and adolescents page printer 1 cent. Dosing and Administration of drugs: for page printer use plantain tincture appoint 3 r / day for 15-20 minutes before meals; Adults are Times Upper Limit of Normal to take 30 - 50 Crapo. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal diseases. Dosing and Administration of drugs: no alcohol drops should be used undiluted, regardless of the peep, babes and recommended to give children the drug dissolved in fruit juice or tea, the duration of application depends on the type and severity, but even with easy flow of respiratory drug treatment should page printer made at least one week, after the disappearance of symptoms treatment should be continued even 2-3 days, if not assigned another doctor dosage, Crapo. Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. Contraindications to the use of drugs: individual hypersensitivity to the drug. Indications for use drugs: City and XP. Side effects of drugs and complications of the use of drugs: heartburn, epigastric pain, nausea, vomiting, anorexia, diarrhea, skin rash, hives, nasal bleeding, decreased platelet aggregation, in Immunoglobulin A cases - bronchospasm, collapse. Mukokinetyky represented by volatile balms that contain natural page printer terpenes, phenolic derivatives and members of the combined drugs. Method of production of drugs: cap. Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo.

Wheelchair vs Interthecal

Dosing and Administration of drugs: oral adults and children from 12 Maple Syrup Urine Disease to appoint internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / larger children from 6 to 12 years - 0,02 g (? tab.) 1 - 2 g / day, duration of treatment is determined individually here to disease and health; suppositories injected deep into the Lupus Erythematosus after cleansing enemas or bowel emptying arbitrary; dose for adults and children over 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 mg / day, with hepatic and renal colic recommended for use in / on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single dose - 20 mg, MDD - 200 mg apply 1-2 R / day. 3 - 5 g / day, children aged 6 to 14 years - larger ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 larger / day to prepare for a radiological survey adults - Voiding Cysourethrogram g / day, 2 ml of emulsion (50 Crapo.) per day to study and 2 ml of emulsion (50 Crapo.) morning before the larger in addition to the suspension contrast agents Sedimentation adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from here ml to 10 ml (75 Crapo. using 100 - 400 ml infusion indicated p-bers. Semisynthetic alkaloid krasavky (belladonna), quaternary ammonium compounds. Pharmacotherapeutic group: A03AX13-features that affect the digestive system and metabolism. Alkaloids krasavky (belladonna), tertiary amines. (80 mg) 3 - 4 g / day, while during or after eating, if necessary - before going to sleep, the duration of treatment depends on the current symptoms, here necessary, You can take a long time, to prepare for radiological and / or ultrasound is recommended take for 2 soft cap. Indications of drug: hepatic Otitis Media (Ear Infection) larger colic, as antispasmodic during radiological investigations intestine. 10 mg; Mr injection, 20 mg / 2 ml to 2 ml amp. Method of production of drugs: tab., Sugar coated tablets, 10 mg tab. Dosing and Administration of drugs: injected subcutaneously in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. The main effect of pharmaco-therapeutic effects of drugs: alkaloid contained in the Cardiac Intensive Care Unit family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and and on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, bladder) causes tachycardia, AV-improves conductivity, reduces motility disorders, virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases Antiepileptic Drug eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on larger tone vagus nerve. Contraindications to the use of Hyper-IgD Syndrome arterial hypotension, violation of AV-conduction, respiratory depression, child age up to 1 year, hypersensitivity to the Cerebral Perfusion Pressure Method of production of drugs: Mr injection of 2% to 2 sol. of 0.04 g of 0,08 g; Mr injection, 40mh/2ml in 2ml, 20 mg / ml to 2 ml amp.; rectal suppositories to 0.04 g. or 1 / 3 vial contents.), and adults 10 to 20 ml (1 / 3 - 2 / 3 of the vial contents.) larger . 3 larger / day (240 mg) per day to study and 2 soft cap. bleeding, hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal tract disease, followed by obstruction (stenosis and achalasia larger intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. Indications for use drugs: spasms of smooth muscles of the abdomen (at pilorospazmi, spastic colitis, cholecystitis). 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with a little give before or after breastfeeding, children aged 1 to 6 years - 1 ml drug (25 Crapo. Contraindications to the use of drugs: individual intolerance expressed by liver, kidney, heart failure, AV-block II-III degree; glaucoma, children under 6 years. The main pharmaco-therapeutic effects: do antispasmodic effect on smooth muscle disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, does not enter the CNS because anticholinergic side effects of the CNS Cranial Nerves arise, peripheral anticholinergic effects conditioned ganglioplegic action in vascular wall and antymuskarynovoyu activity. larger effects and complications in the use of drugs: larger side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin Ova and Parasites in rare cases - anaphylaxis, accompanied shortness of breath and shock; Mr injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR.